Asymptomatic Stage G5 CKD: When to Treat, When to Dialyze, When to Refer for Access
Mr. A is 61 with CKD from type 2 diabetes. Current eGFR 15 mL/min/1.73 m², potassium 5.7 mmol/L, bicarbonate 17 mmol/L, phosphate 6.2 mg/dL, corrected calcium 8.6 mg/dL, PTH 310 pg/mL, hemoglobin 9.4 g/dL, ferritin 180 ng/mL, TSAT 22%. He has no nausea, pruritus, or anorexia, sleeps well, and makes 1.2 L of urine daily. He works full time as a truck dispatcher and says he is "not ready" for dialysis. Medications: losartan 50 mg daily, furosemide 40 mg daily, calcium carbonate 1250 mg with meals, and a multivitamin. He has no vascular access and no vein mapping. The nephrologist asks you to help plan the next 6 months.
1. Which of his laboratory abnormalities need action at this visit, and which can be monitored? Prioritize your actions and justify each choice.
Read the worked answer
Priority 1 – Potassium 5.7 mmol/L. This is the abnormality most likely to cause acute harm and the most common reason a patient converts from planned to emergency dialysis. Act now: review dietary potassium (including salt substitutes), stop any NSAIDs or herbal supplements, check for sample hemolysis, and confirm the losartan dose. Rather than stopping losartan reflexively, consider adding a potassium binder (patiromer or sodium zirconium cyclosilicate) so that kidney-protective RAAS blockade can continue; document the ECG if any symptoms or K >6.0.
Priority 2 – Bicarbonate 17 mmol/L. Chronic metabolic acidosis drives protein catabolism, bone demineralization, and faster eGFR decline. Start oral sodium bicarbonate titrated to keep bicarbonate 22–23 mmol/L, monitoring blood pressure, edema, and sodium intake, since he is also on a loop diuretic.
Priority 3 – Phosphate 6.2 mg/dL. He is already taking a calcium-based binder with meals, so first check timing and dietary intake. If calcium rises or binder burden is high, switch to a non-calcium binder. This is a trend-and-adjust issue rather than an emergency.
Monitor – Anemia and PTH. Hb 9.4 g/dL with TSAT 22% and ferritin 180 ng/mL means iron stores are adequate; do not load iron, but screen for blood loss and B12/folate deficiency. PTH 310 pg/mL with normal calcium and phosphate needs trending, not urgent intervention.
2. The nephrologist proposes starting hemodialysis next month. Is that justified by the data in this case? What findings would make dialysis genuinely urgent?
Read the worked answer
The decision rests on symptoms and complications, not on the eGFR number alone. This patient has no uremic symptoms (no nausea, anorexia, pruritus, sleep disturbance, restless legs, or cognitive change), preserved urine output of 1.2 L/day, and a potassium that is manageable with medical therapy. Starting dialysis "next month" solely because eGFR is 15 is not supported; an asymptomatic patient begun on dialysis at a given eGFR does not gain a survival advantage, and the burden of a catheter or new access carries real risk.
The defensible plan is shared decision-making: quantify his trajectory (e.g., kidney failure risk equation 2-year risk), explain what dialysis will and will not change, and agree on a review interval with clear escalation triggers. He should be told that preparation is not commitment.
Findings that would make dialysis urgent: hyperkalemia refractory to diet and binders (particularly with ECG changes); pulmonary edema or volume overload unresponsive to diuretics; uremic pericarditis; uremic encephalopathy, asterixis, or new neuropathy; bleeding attributable to uremic platelet dysfunction; and severe acidosis that does not respond to bicarbonate. Uremic symptoms that interfere with eating or function belong on that list too. If any appear, the plan shifts immediately from preparation to access-and-start.
3. What vascular access plan and vein-preservation teaching do you recommend now?
Read the worked answer
Refer now for access evaluation with vein mapping, not when dialysis becomes urgent. A functioning arteriovenous fistula typically needs 3–6 months to mature, and he is likely to reach kidney failure within that window. Referring now costs him nothing if his kidney function stabilizes and buys him the option of avoiding a tunneled catheter, which carries the highest infection and central-vein stenosis risk of any access.
Protect the veins of both forearms. Specifically: no PICC lines or subclavian catheters unless there is no alternative; no blood draws, IV starts, or blood pressure cuffs in the planned access arm once identified; phlebotomy from the dorsum of the hand when possible. Flag his chart.
Discuss all modalities, not just in-center hemodialysis. Peritoneal dialysis preserves his veins and offers schedule flexibility that matters for a full-time dispatcher; home hemodialysis is another option. Presenting only one modality is a failure of informed consent.
Teaching points, delivered with teach-back: why early referral matters, that having a fistula does not mean he must start dialysis, hand/arm exercises if prescribed, signs of a failing or infected access, and whom to call. Document his stated preference and his "not ready" position without judgment-the goal is to keep options open, not to pressure.